Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants

BACKGROUND: Rabbit antithymocyte globulin (rATG, Thymoglobulin®) is the most common induction immunosuppression therapy in kidney transplantation. We applied a database integration strategy to capture and compare long-term (10-year) outcome data for US participants in a clinical trial of rATG versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Lentine, Krista L., Schnitzler, Mark A., Xiao, Huiling, Brennan, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545548/
https://www.ncbi.nlm.nih.gov/pubmed/26285695
http://dx.doi.org/10.1186/s13063-015-0891-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545548/
https://www.ncbi.nlm.nih.gov/pubmed/26285695
http://dx.doi.org/10.1186/s13063-015-0891-y

Ejemplares similares